MURPHY ANDREW J sold REGN

March 14, 2024 · Form 4 insider transaction

MURPHY ANDREW J sold 1 shares of Regeneron Pharmaceuticals, Inc. at $962.87 per share, a transaction worth $962.87. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
1
Price
$962.87
Total value
$962.87
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 14, 2024
Filing dateMarch 15, 2024
Shares owned after48,597
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.

View the original Form 4 on SEC EDGAR
MURPHY ANDREW J sold REGN: March 14, 2024 | Insider Trading Screener